MDGL Net Income Growth
Madrigal Pharmaceuticals Inc · Net Income Growth
MDGL Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-15.32%period ending
MDGL TTM Net Income YoY % (25.89% → -15.32%)
Year-over-year change
High-resolution chart · PNG
MDGL net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -15.3232% | |
| 20.9791% | |
| 38.1221% | |
| 44.2565% | |
| 44.774% | |
| 11.8589% | |
| -24.6934% | |
| -49.3259% | |
| -54.7753% | |
| -41.1616% | |
| -26.5041% | |
| -26.7696% | |
| -28.8792% | |
| -27.5142% | |
| -22.1232% | |
| -15.8929% | |
| -10.6424% | |
| -12.8801% | |
| -19.5813% | |
| -38.3698% | |
| -72.1791% | |
| -108.2369% | |
| -140.9158% | |
| -152.443% | |
| -145.2744% | |
| -152.8548% | |
| -155.8532% | |
| -127.2691% | |
| -84.8205% | |
| -31.7523% | |
| -5.3187% | |
| 2.2236% | |
| 18.0168% | |
| -2.7547% | |
| 0.1443% | |
| 10.3793% | |
| 3.7828% | |
| 43.705% | |
| 54.5674% | |
| 56.6989% | |
| 53.523% | |
| 34.5969% | |
| 20.2992% | |
| 12.7641% | |
| 12.6405% | |
| 10.4385% | |
| 4.4694% | |
| -6.9136% | |
| -20.7297% | |
| -35.8625% | |
| -43.6407% | |
| -51.8733% | |
| -44.1898% | |
| -34.1701% | |
| -32.5243% | |
| -21.8874% | |
| -23.6345% | |
| -28.9939% | |
| -26.4579% | |
| -27.4067% | |
| -146.3732% | |
| -142.4104% | |
| -147.3738% | |
| -159.2983% | |
| 210.0062% | |
| 194.7312% | |
| 185.3916% | |
| 173.2117% | |
| -19.1185% | |
| -51.9787% | |
| -45.8666% | |
| -35.944% | |
| -18.8758% | |
| -12.2935% | |
| -12.8399% | |
| -1.9958% | |
| 17.3862% | |
| 31.1426% | |
| 35.1138% | |
| 25.8933% |